Licensor retains Sample Clauses

Licensor retains the sole right and discretion, but not the obligation, to file and prosecute patent applications and maintain patents in the Territory relating to the Technology or any improvements made by Licensor. At Licensee's request, Licensor will discuss its decision on these matters with Licensee, but Licensee will not attempt to file or prosecute any such patent applications or maintain any such patents except as Licensor may, at its sole discretion, approve in writing. Any improvements to Technology (whether or not patentable or copyrightable) that either party develops shall be owned solely by such party. Such party shall have the right, at its own expense and solely in its own name, to apply for, prosecute and defend its intellectual property rights with respect thereto. Licensee agrees to place on all Products in a proper manner all reasonable patent and patent application markings requested by Licensor.
Sample 1
AutoNDA by SimpleDocs
Licensor retains all rights in the Source Code and the Software and the right of modification granted in Section 2.4.4 does not modify any of such rights. Notwithstanding the foregoing, Licensee shall be the sole owner of the Licensee Derivative Works. Licensee hereby grants to Licensor a non-exclusive, irrevocable, royalty free license, with the right to sublicense to Licensor's Affiliates, to use, reproduce and modify the Licensee Derivative Works. Licensee agrees to execute (in recordable form where appropriate) any instruments and/or documents as Licensor may reasonably request to give effect to this Section 2.4.5 and Section 2.4.7.
Sample 1
Licensor retains. (i) the right under Licensed Patents, Licensed Proprietary Technology, Licensed Trademarks, and to the Product for research, development and clinical testing of New Products, technology, Improved Products, additional products not included within the scope of the Exclusive License granted to Horus under this Agreement, and additional therapeutic indications (including but not limited to Total Body Washout and uses other than Normothermic Use) of the Product and Improved Products inside and outside the Territory; and (ii) all rights to Licensed Patents, Licensed Proprietary Technology, Licensed Trademarks, and the Product for any purpose outside the Territory, including but not limited to the right to sell, assign, transfer and license to Third Persons, and the right to make, have made, use, and sell the Product, Improved Products and New Products outside the Territory.
Sample 1
Licensor retains and Licensee hereby acknowledges that Licensor retains, all right, title and interest in and to the Technical Information, Intellectual Property Rights, Proprietary Software, Database, Trademarks, Proprietary Information and Improvements, and to the extent that Improvements or Intellectual Property Rights were developed by or on behalf of Licensee, Licensee shall assign and hereby does assign all right, title and interest in and to the Improvements or Intellectual Property Rights. Licensee shall execute any and all documents deemed necessary or appropriate by the Licensor to accomplish the assignments of the Improvements and Intellectual Property Rights as contemplated by this Section 3.1. Further, Licensee will cooperate with the Licensor to achieve assignment of such Improvements or Intellectual Property Rights, and will aid in any application or registration and protection of such Improvements or Intellectual Property Rights, at the expense of the Licensor. Further, Licensee will timely notify the Licensor of any such Improvements or Intellectual Property Rights, and copies of the Improvements or Intellectual Property Rights shall be timely provided to the Licensor, on appropriate media.
Sample 1
Licensor retains all benefits and burdens of ownership of the intellectual property rights contained in the Technical Documentation licensed under this Agreement, and is entitled to grant future licenses to others under such Technical Documentation to the extent such future licenses do not conflict with this Agreement.
Sample 1
Licensor retains all benefits and burdens of ownership of the intellectual property rights53 contained in the Technical Documentation licensed under this Agreement, and is entitled to54 grant future licenses to others under such Technical Documentation to the extent such future licenses do not conflict with this Agreement. - 제3자에게 라이센스 허여가 가능함을 명시화함. 위 3.1조항과 중복되어 꼭 필요한 조항은 아님.
Sample 1

Related to Licensor retains

  • Licensor any Person from whom a Grantor obtains the right to use any Intellectual Property. Lien: any Person’s interest in Property securing an obligation owed to, or a claim by, such Person, whether such interest is based on common law, statute or contract, including liens, security interests, pledges, hypothecations, statutory trusts, reservations, exceptions, encroachments, easements, rights-of-way, covenants, conditions, restrictions, leases, and other title exceptions and encumbrances affecting Property. Lien Waiver: an agreement, in form and substance satisfactory to Collateral Agent, by which (a) for any material Collateral located on leased premises, the lessor waives or subordinates any Lien it may have on the Collateral, and agrees to permit Collateral Agent to enter upon the premises and remove the Collateral or to use the premises to store or dispose of the Collateral; (b) for any Collateral held by a warehouseman, processor, shipper, customs broker or freight forwarder, such Person waives or subordinates any Lien it may have on the Collateral, agrees to hold any Documents in its possession relating to the Collateral as agent for Collateral Agent, and agrees to deliver the Collateral to Collateral Agent upon request; (c) for any Collateral held by a repairman, mechanic or bailee, such Person acknowledges Collateral Agent’s Lien, waives or subordinates any Lien it may have on the Collateral, and agrees to deliver the Collateral to Collateral Agent upon request; and (d) for any Collateral subject to a Licensor’s Intellectual Property rights, the Licensor grants to Collateral Agent the right, vis-à-vis such Licensor, to enforce Collateral Agent’s Liens with respect to the Collateral, including the right to dispose of it with the benefit of the Intellectual Property, whether or not a default exists under any applicable License.

  • Licensee Licensee represents and warrants that:

  • Sublicensee The term “

  • Licensed Rights (a) (i) BNYM hereby grants to Company a limited, nonexclusive, nontransferable license to access and use the Licensed System in the United States through its employees (other than as expressly permitted otherwise by Section 2.1(a)(ii) below), solely in accordance with applicable Documentation, through the interfaces and telecommunication lines designated by BNYM, strictly for the internal business purposes of the Company, solely in support of the Core Services and solely for so long as any applicable fees are paid by Company.

  • Sublicense (a) The license granted in Paragraph 2.1 includes the right of LICENSEE to grant Sublicenses to third parties during the Term but only for as long as the license to Patent Rights is exclusive.

  • Sublicense Fees Licensee will pay Sublicense Fees indicated in Section 3.1(e) of the Patent & Technology License Agreement on or before the Quarterly Payment Deadline for the Contract Quarter.

  • Sublicensing Rights Novartis and its Affiliates may grant sublicenses of the license granted in Section 5.3.1(a), Section 5.3.2, and Section 5.3.3, and Intellia and its Affiliates may grant sublicenses of the license granted in Section 5.3.1(b), provided that (a) such sublicense (i) is in writing, (ii) is subject and subordinate to, and consistent with, the terms and conditions of this Agreement, and (iii) requires the applicable sublicensee to comply with all applicable terms of this Agreement [***]; (b) with respect to Novartis or any of its Affiliates as the sublicensing Party to the extent required by the Key License Agreements as in effect on the Effective Date or the agreements for any Included Intellia New In-Licensed Intellectual Property, Novartis promptly notifies Intellia of the grant of each sublicense and provides Intellia a copy of the final executed sublicense agreement, redacted for information not pertinent to this Agreement to the extent that such redactions do not reasonably impair Intellia’s ability to ensure compliance with this Agreement, the Key License Agreements or agreements for any Included Intellia New In-Licensed Intellectual Property, as applicable, (c) Novartis or Intellia, as applicable, shall be responsible for the failure by its sublicensees to comply with, and Novartis or Intellia, as applicable, guarantees the compliance by each of its sublicensees with, all relevant restrictions, limitations and obligations in this Agreement, and [***]. CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH “[***]”. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 406 PROMULGATED UNDER THE SECURITIES ACT OF 1933, AS AMENDED.

  • Research License Each Collaborator shall allow the other Collaborator to practice any of its Non- Subject Inventions for the purpose of performing the Cooperative Work. No license, express or implied, for commercial application(s) is granted to either Collaborator in Non-Subject Inventions by performing the Cooperative Work. For commercial application(s) of Non-Subject Inventions, a license must be obtained from the owner.

  • Sublicense Income Company shall pay Medical School {***} of all Sublicense Income. Such amounts shall be due and payable within sixty (60) days after Company receives the relevant payment from the Sublicensee.

  • Licensed Technology The term "Licensed Technology" shall mean the ------------------- Licensed Patents, plus all improvements thereto developed by Licensor, and all related data, know-how and technology.

Time is Money Join Law Insider Premium to draft better contracts faster.